http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106806365-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2017-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106806365-B |
| titleOfInvention | Purposes of the psoralen in preparation treatment hyperlipidemia |
| abstract | The invention belongs to pharmaceutical technology fields, are related to psoralen in the purposes of preparation treatment hyperlipidemia, first passage pharmacological testing discovery psoralen of the present invention has therapeutic effect well to olive Antihyperlipidemia capsule.The therapeutic effect for feeding the hyperlipidemia disorders of lipid metabolism rat model established to high lipid food for psoralen carries out system research, as the result is shown: psoralen has the therapeutic effect of significant ground to olive Antihyperlipidemia capsule, psoralen can be such that the total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C) of hyperlipidemia rats reduces, high-density lipoprotein cholesterol (HDL-C) increases, and has the function of while reducing hyperlipidemia rats cholesterol and triglycerides. |
| priorityDate | 2017-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.